Patients Coming Off Weight-Loss Medications Gain Back Pounds at a Quadrupled Rate Than People Using Diet and Exercise

Fresh analysis reveals that individuals who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy can put back on shed pounds far faster than those who end conventional lifestyle plans.

Published data in a major health publication points out that while obese people frequently drop a large proportion of their total mass while on the medication, the weight is regained at an average rate of nearly a kilo each month once they quit.

"People purchasing these drugs need to be aware of the risk of rapid weight regain when the treatment ends," cautioned researcher Dr. Susan Jebb.

Such speed of regain means a reversion to original weight within about a year and a half.

Analyzing Approaches

The analysis, which looked at dozens of trials involving thousands of patients, contrasted the results of the injectable medications with other pills.

Scientists point out that individuals who lose weight through lifestyle changes alone usually experience a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.

Explaining the Fast Rebound

Experts believe the mode of action of the jabs accounts for the amplified weight return.

The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous hormone, and may also lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this GLP-1 'fix' results in hunger is no longer kept in check, making binge eating much more probable."

An Ongoing Issue?

Medical guidelines advise the jabs for people with obesity-related medical conditions, alongside prescribed lifestyle changes.

A number of clinicians argue that, due to the likelihood of relapse, the therapy is often ongoing.

This opinion is echoed by pharmaceutical companies, who state that the findings "emphasize the persistent character of obesity," akin to managing conditions like hypertension.

Patient Experiences

Users who have stopped the jabs describe a powerful return of cravings.

"It felt as if a trigger activating and you're instantly extremely hungry," recalled an individual.

This difficulty is worsened if patients have not adopted permanent dietary or behavioural changes during therapy.

Widespread Use

Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.

• Use is more common among females compared to males.
• The middle-aged demographic shows the highest usage rates.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

Ultimately, clinicians caution that while these medications are powerful agents for shedding pounds, they are not a magic cure and lasting health benefits relies on integrated behavioural support.